Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRevision v3.6.3 was added to the history, replacing the previous v3.6.2 entry. It reflects a site software update rather than changes to study data or publicly visible content.SummaryDifference0.0%

- Check8 days agoChange DetectedA new revision entry v3.6.2 was added to the record history and the previous v3.6.0 entry was removed, updating the page's version metadata.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRecruitment status updated to no longer looking for participants, and the study record version was updated to v3.6.0, replacing v3.5.5.SummaryDifference0.2%

- Check29 days agoChange DetectedAn updated Revision: v3.5.5 entry is now shown in the page's version history, indicating the latest revision. The prior Revision: v3.5.4 entry has been removed or superseded by the new version.SummaryDifference0.0%

- Check50 days agoChange DetectedA new release tag Revision: v3.5.4 was added to the record history, and the previous tag Revision: v3.5.3 was removed. This reflects a minor platform update to the page's revision tracking.SummaryDifference0.0%

- Check72 days agoChange DetectedThe revision/build displayed on the page footer was updated from **v3.5.0** to **v3.5.3**, reflecting a minor technical release rather than a change to the clinical trial record.SummaryDifference0.0%

Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.